OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,809,000 | -15.1% | 574,555 | -30.3% | 0.00% | 0.0% |
| Q3 2016 | $5,664,000 | +47.5% | 824,426 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $3,839,000 | -43.5% | 775,611 | +10.2% | 0.00% | -50.0% |
| Q1 2016 | $6,798,000 | +4.6% | 703,729 | +1.5% | 0.00% | +100.0% |
| Q4 2015 | $6,497,000 | +17.7% | 693,409 | +76.7% | 0.00% | 0.0% |
| Q3 2015 | $5,518,000 | -24.0% | 392,453 | +13.6% | 0.00% | -50.0% |
| Q2 2015 | $7,262,000 | +6.7% | 345,336 | +113.0% | 0.00% | 0.0% |
| Q1 2015 | $6,806,000 | +83.5% | 162,100 | +2.8% | 0.00% | +100.0% |
| Q4 2014 | $3,710,000 | +75.1% | 157,739 | +11.4% | 0.00% | 0.0% |
| Q3 2014 | $2,119,000 | – | 141,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |